By Josh White
Date: Friday 08 May 2026
(Sharecast News) - Trellus Health said on Friday that its shares had been suspended from trading on AIM as it continued to seek long-term funding and evaluate options including the potential sale of its US subsidiary.
The healthcare company, which delivers the Trellus Elevate digital platform for managing complex chronic conditions,...
or login to read the full story
Email this article to a friend
or share it with one of these popular networks:
You are here: news